Michael Goldberg Sample Contracts

SEC Documents
Filings
Personal financials
Insider transactions
Previous Companies
director until August 13th, 2009
director until June 30th, 2010
director until May 14th, 2012
director until August 22nd, 2007
Emisphere Technologies Inc – AMENDMENT TO EMPLOYMENT AGREEMENT BY AND BETWEEN EMISPHERE TECHNOLOGIES, INC. AND MICHAEL M. GOLDBERG, M.D. (March 3rd, 2005)

THIS AMENDMENT TO EMPLOYMENT AGREEMENT (the “Amendment”), effective as of December 15, 2004, is entered into by and between Emisphere Technologies, Inc., a Delaware corporation with principal offices at 765 Old Saw Mill River Road, Tarrytown, New York 10591 (the “Employer”), and Michael M. Goldberg, M.D. (the “Executive”).

Emisphere Technologies Inc – AMENDMENT TO EMPLOYMENT AGREEMENT BY AND BETWEEN EMISPHERE TECHNOLOGIES, INC. AND MICHAEL M. GOLDBERG, M.D. (February 1st, 2005)

THIS AMENDMENT TO EMPLOYMENT AGREEMENT (the “Amendment”), effective as of December 15, 2004, is entered into by and between Emisphere Technologies, Inc., a Delaware corporation with principal offices at 765 Old Saw Mill River Road, Tarrytown, New York 10591 (the “Employer”), and Michael M. Goldberg, M.D. (the “Executive”).

Emisphere Technologies Inc – FOR RELEASE EMISPHERE ANNOUNCES SECOND QUARTER FINANCIAL RESULTS FOR 2003 - PROVIDES UPDATE ON DEVELOPMENT PROGRAMS- Tarrytown, NY - August 12, 2003 - Emisphere Technologies, Inc. (Nasdaq: EMIS) today announced financial results for the second quarter ended June 30, 2003. The Company also provided an update on development programs involving its proprietary eligen(TM) oral drug delivery technology. "Most notably in the second quarter, we executed on our key strategic objective of creating improved dosage forms of our lead product candidates," commented Michael M. Goldberg, M.D., Chairman and Ch (August 18th, 2003)

For the three months ended For the six months ended June 30, June 30, ----------------------------- ----------------------------- 2003 2002 2003 2002 ----------- ----------- ----------- ----------- Contract research revenues $ 246 $ 1,089 $ 272 $ 1,818 ----------- ----------- ----------- ----------- Costs and expenses: Research and development 5,430 15,582

Emisphere Technologies Inc – Page ---- 1. Definitions....................................................... .............................. 1 2. Term of Employment......................... ..................................................... 2 3. Position, Duties and Responsibilities........................................................... 2 4. Base Salary................................................................. .................... 3 5. Annual Incentive Awards......................................................................... 3 6. Long-Term Stock Incentive Programs........................................... (October 25th, 2000)

EMPLOYMENT AGREEMENT -------------------- AGREEMENT, made and entered into as of the 31st day of July, 2000 by and between Emisphere Technologies, Inc., a Delaware corporation with principal offices at 765 Old Saw Mill River Road, Tarrytown, New York 10591 (together with its successors and assigns, the "Company" or Emisphere, and Michael M. Goldberg, M.D. (the "Executive"). W I T N E S S E T H: - - - - - - - - - - WHEREAS, Emisphere desires to employ Executive pursuant to an agreement embodying the terms of such employment (this "Agreement") and Executive desires to enter into this Agreement and to accept such employment, subject to the terms and provisions of this Agreement; NOW, THEREFORE, in consideration of the premises and mutual covenants contained herein and for other good and valuable consideration, the receipt of which is mutually acknowledged, Emisphere and Ex

Emisphere Technologies Inc – ORAL CALCITONIN LICENSE AGREEMENT (February 17th, 2000)
Emisphere Technologies Inc – OF PREFERRED STOCK PURCHASE RIGHTS (October 22nd, 1996)